UPDATE : Monday, September 7, 2020
상단여백
248 drugs taken off the market for low profitability
The sales of 248 medicines were stopped because of low profitability betwee...
by Kwak Sung-sun  |  2017-07-28 16:39
라인
Chinese control of biological resources alerts Korean drugmakers
The Chinese government will likely implement a decree this year, which forc...
by Nam Doo-hyun  |  2017-07-28 14:14
라인
Domestic pharmaceuticals’ Q2 earnings surprise investors
Domestic pharmaceutical companies’ coffers are overflowing with cash, thank...
by Constance Williams  |  2017-07-28 12:05
라인
Green Cross’ 2Q operating profit jumps 43.6%
Green Cross announced Wednesday that its operating profit in the second qua...
by Lee Hye-seon  |  2017-07-27 16:35
라인
Celltrion show record-high performances in Q2
Celltrion recorded sales of 246.1 billion won ($221 million), and operating...
by Nam Doo-hyun  |  2017-07-27 15:51
라인
Ildong’s 3-compound hypertension drug wins approval
Ildong Pharmaceutical received the approval for its three-compound hyperten...
by Lee Hye-seon  |  2017-07-27 11:15
라인
Samsung Bioepis makes most of US ruling on biosimilars
Samsung Bioepis said Tuesday it would launch Johnson & Johnson’s Remicade b...
by Marian Chu  |  2017-07-26 10:39
라인
Merck succeeds in P3 trial for HIV-1 infection drug
Merck has succeeded in its Phase 3 trial for doravirine, an HIV-1 infection...
by Marian Chu  |  2017-07-26 10:32
라인
Dong-A ST hit by penalty for illegal rebates
The Ministry of Health and Welfare has decided to impose a penalty on Dong-...
by Marian Chu  |  2017-07-25 13:55
라인
Hanmi expects blockbuster from hypertension-hyperlipidemia complex
Hanmi Pharm has recently won the approval for its hypertension- hyperlipide...
by Lee Hye-seon  |  2017-07-25 13:55
라인
Huons’ saline injection gets ANDA approval from FDA
Huons, a subsidiary of Huons Global Inc., has won an Abbreviated New Drug A...
by Constance Williams  |  2017-07-24 15:25
라인
GSK launches Internet portal for healthcare professionals
GSK Korea has launched health.gsk.kr, a healthcare platform for Korean medi...
by Marian Chu  |  2017-07-24 12:05
라인
Saxenda lands in Korea as obesity therapy
Korean regulators have approved Saxenda, an antiobestic drug developed from...
by Lee Hye-seon  |  2017-07-24 11:45
라인
Daewoong's Botox product accepted for review by EMA, FDA
Daewoong Pharma대웅제약’s NABOTA나보타(development name DWP-450), a Botulinum toxi...
by Constance Williams  |  2017-07-21 16:43
라인
Hand, arm transplants to come under state management
The Ministry of Health and Welfare said Friday it would amend enforcement d...
by Marian Chu  |  2017-07-21 11:06
라인
Pfizer Korea launches new Centrum products
Pfizer Korea Consumer Healthcare한국화이자 컨슈머헬스케어 unveiled its wellness busines...
by Constance Williams  |  2017-07-20 15:22
라인
Ministry ferrets out fake erectile dysfunction, obesity drugs
The Ministry of Food and Drug Safety said Wednesday it identified two compo...
by Marian Chu  |  2017-07-19 17:03
라인
Hanmi’s Esomezol is 1st Korean drug enrolled on US Pharmacopoeia
The United States Pharmacopoeia (USP) has enrolled Hanmi Pharmaceutical’s r...
by Marian Chu  |  2017-07-19 11:42
라인
Gilead gets FDA approval for hepatitis C drug
The U.S. Food and Drug Administration Tuesday approved Gilead’s Vosevi as a...
by Marian Chu  |  2017-07-19 10:29
라인
Global clinical trials decline but Korea’s share rises
The number of clinical trials (phase 1 – phase 3) has decreased for t...
by Lee Hye-seon  |  2017-07-18 16:54
-이전111112113114115116117118119120-
176 civic groups furious over government-doctors deal176 civic groups furious over government-doctors deal
여백
Most viewed
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top